Ultralife CORP 10-Q quarterly reports

Ultralife Corporation reported improved gross margins and net income in Q2 2026 compared to the prior year, driven by favorable product mix and tariff refunds, with a record backlog of $117.5 million.

Ultralife Corporation reported a 6.5% decrease in revenue for the first quarter of 2026 compared to the prior year, driven by declines in both commercial and government/defense sales.

Ultralife Corporation reported a net loss for Q3 2025, driven by increased operating expenses, higher interest costs from its Electrochem acquisition, and declining gross margins, despite overall revenue growth.

Ultralife Corporation reported a significant decline in second-quarter net income and EPS despite revenue growth driven by its recent Electrochem acquisition, facing increased operating expenses and interest costs.

Ultralife Corporation's Q1 2025 revenue increased by 21% year-over-year, primarily due to the acquisition of Electrochem and growth in government/defense sales, though profitability was impacted by sales mix and increased operating expenses.

Ultralife Corporation's Q3 2024 results show a revenue decrease and increased operating expenses, alongside the strategic acquisition of Electrochem Solutions, Inc.

Ultralife Corporation's Q2 2024 results show a slight revenue increase and improved gross profit, driven by strong performance in the Battery & Energy Products segment.

Ultralife Corporation's first quarter of 2024 saw a significant increase in revenue and profitability compared to the same period last year, overcoming challenges from a prior cybersecurity incident.